🇺🇸 FDA
Patent

US 9315463

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

granted A61KA61K31/4709A61P

Quick answer

US patent 9315463 (Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities) held by Almirall, S.A. expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/4709, A61P, A61P1/00, A61P11/00